MMBO structure
|
Common Name | MMBO | ||
---|---|---|---|---|
CAS Number | 1005203-15-5 | Molecular Weight | 338.380 | |
Density | 1.4±0.0 g/cm3 | Boiling Point | 579.0±0.0 °C at 760 mmHg | |
Molecular Formula | C18H14N2O3S | Melting Point | N/A | |
MSDS | N/A | Flash Point | 304.0±0.0 °C |
Use of MMBOMMBO is a potent, highly selective, brain penetrant, orally active inhibitor of GSK-3 with IC50 of 37 and 53 nM for GSK-3α and GSK-3β, respectively; inhibits tau phosphorylation in primary neural cell culture and also in normal mouse brain, significantly decreases hippocampal tau phosphorylation at GSK-3 sites in transgenic mouse model of AD; suppresses tau pathology as assessed by AT8-immunoreactivity without affecting amyloid β pathology, significantly improves memory and cognitive deficits in AD models. |
Name | 2-Methyl-5-(3-{4-[(S)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole |
---|---|
Synonym | More Synonyms |
Description | MMBO is a potent, highly selective, brain penetrant, orally active inhibitor of GSK-3 with IC50 of 37 and 53 nM for GSK-3α and GSK-3β, respectively; inhibits tau phosphorylation in primary neural cell culture and also in normal mouse brain, significantly decreases hippocampal tau phosphorylation at GSK-3 sites in transgenic mouse model of AD; suppresses tau pathology as assessed by AT8-immunoreactivity without affecting amyloid β pathology, significantly improves memory and cognitive deficits in AD models. |
---|---|
References | References 1. Onishi T, et al. J Neurochem. 2011 Dec;119(6):1330-40. View Related Products by Target GSK-3 |
Density | 1.4±0.0 g/cm3 |
---|---|
Boiling Point | 579.0±0.0 °C at 760 mmHg |
Molecular Formula | C18H14N2O3S |
Molecular Weight | 338.380 |
Flash Point | 304.0±0.0 °C |
Exact Mass | 338.073000 |
LogP | 2.27 |
Vapour Pressure | 0.0±0.0 mmHg at 25°C |
Index of Refraction | 1.713 |
1,3,4-Oxadiazole, 2-methyl-5-[3-[4-[(S)-(1S)-methylsulfinyl]phenyl]-5-benzofuranyl]- |
2-Methyl-5-(3-{4-[(S)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole |